SCHEMBL30065660

SCHEMBL30065660

Nc1cccc2cncc(Br)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.46
LMNA P02545 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
AXL P30530 2/20 0.39
BACE1 P56817 2/20 0.37
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
TSHR P16473 3/20 0.35
HSD17B10 Q99714 2/20 0.35
KEAP1 Q14145 1/20 0.35
IMPDH2 P12268 1/20 0.35
JAK2 O60674 1/20 0.35
RPS6KA3 P51812 1/20 0.35
MELK Q14680 1/20 0.35
STK24 Q9Y6E0 1/20 0.35
NOS1 P29475 1/20 0.33
PRKCZ Q05513 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4531509 1.00 CYP3A4 (0.46) CYP3A4LMNACYP1A2CYP2D6CYP2C9
SCHEMBL9871846 0.90 CYP3A4 (0.46) CYP3A4LMNACYP1A2CYP2D6CYP2C9
SCHEMBL17301339 0.84 BACE1 (0.41) CYP3A4LMNACYP1A2CYP2D6CYP2C9
SCHEMBL637008 0.81 CYP3A4 (0.50) CYP3A4LMNACYP1A2CYP2D6CYP2C9
SCHEMBL31732851 0.81 CYP3A4 (0.50) CYP3A4LMNACYP1A2CYP2D6CYP2C9
SCHEMBL29556272 0.81 NOS1 (0.41) CYP3A4LMNACYP1A2CYP2D6CYP2C9
SCHEMBL26011167 0.80 BACE1 (0.33) CYP3A4LMNACYP1A2CYP2D6CYP2C9
SCHEMBL30545244 0.80 BACE1 (0.33) CYP3A4LMNACYP1A2CYP2D6CYP2C9
SCHEMBL31038488 0.76 JAK2 (0.45) CYP3A4LMNACYP1A2CYP2D6CYP2C9
SCHEMBL4087754 0.76 JAK2 (0.45) CYP3A4LMNACYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4087573-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2022-11-16 EP disclosed